These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 180564)

  • 1. New directions in human biochemical genetics: understanding the manifestations of receptor deficiency states.
    Brown MS; Goldstein JL
    Prog Med Genet; 1976; 1():103-19. PubMed ID: 180564
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial hypercholesterolemia: unraveling a genetic receptor disease.
    Brown MS; Goldstein JL
    Trans Assoc Am Physicians; 1977; 90():91-108. PubMed ID: 205984
    [No Abstract]   [Full Text] [Related]  

  • 3. Familial hypercholesterolemia: A genetic defect in the low-density lipoprotein receptor.
    Brown MS; Goldstein JL
    N Engl J Med; 1976 Jun; 294(25):1386-90. PubMed ID: 177875
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of the familial hypercholesterolemia gene in heterozygotes: model for a dominant disorder in man.
    Goldstein JL; Brown MS
    Trans Assoc Am Physicians; 1974; 87():120-31. PubMed ID: 4376290
    [No Abstract]   [Full Text] [Related]  

  • 5. Receptor-mediated control of cholesterol metabolism.
    Brown MS; Goldstein JL
    Science; 1976 Jan; 191(4223):150-4. PubMed ID: 174194
    [No Abstract]   [Full Text] [Related]  

  • 6. Localization of low density lipoprotein receptors on plasma membrane of normal human fibroblasts and their absence in cells from a familial hypercholesterolemia homozygote.
    Anderson RG; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2434-8. PubMed ID: 181751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man.
    Brown MS; Goldstein JL
    Science; 1974 Jul; 185(4145):61-3. PubMed ID: 4366052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.
    Goldstein JL; Brown MS
    J Biol Chem; 1974 Aug; 249(16):5153-62. PubMed ID: 4368448
    [No Abstract]   [Full Text] [Related]  

  • 9. The LDL receptor and HMG-CoA reductase--two membrane molecules that regulate cholesterol homeostasis.
    Brown MS; Goldstein JL
    Curr Top Cell Regul; 1985; 26():3-15. PubMed ID: 4075823
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholesterol synthesis and uptake by fat cells in familial hypercholesterolemia.
    Kovanen PT; Nikkilä EA
    Adv Exp Med Biol; 1977; 82():286-9. PubMed ID: 200097
    [No Abstract]   [Full Text] [Related]  

  • 11. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.
    Basu SK; Goldstein JL; Anderson GW; Brown MS
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3178-82. PubMed ID: 184464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of mutant fibroblasts in the analysis of the regulation of cholesterol metabolism in human cells.
    Brown MS; Brannan PG; Bohmfalk HA; Brunschede GY; Dana SE; Helgeson J; Goldstein JL
    J Cell Physiol; 1975 Apr; 85(2 Pt 2 Suppl 1):425-36. PubMed ID: 164479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mutations affecting the low density lipoprotein pathway.
    Brown MS; Goldstein JL
    Curr Concepts Nutr; 1979; 8():173-8. PubMed ID: 230940
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding, internalization, and hydrolysis of low density lipoprotein in long-term lymphoid cell lines from a normal subject and a patient with homozygous familial hypercholesterolemia.
    Ho YK; Brown MS; Kayden HJ; Goldstein JL
    J Exp Med; 1976 Aug; 144(2):444-55. PubMed ID: 182894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biochemistry of familial hypercholesterolaemia.
    Myant NB
    Biochem Soc Trans; 1976; 4(4):580-4. PubMed ID: 187482
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperlipidemia in coronary heart disease: a biochemical genetic approach.
    Goldstein JL; Brown MS
    J Lab Clin Med; 1975 Jan; 85(1):15-25. PubMed ID: 49382
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor.
    Goldstein JL; Dana SE; Brunschede GY; Brown MS
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):1092-6. PubMed ID: 236556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mutations affecting the low density lipoprotein pathway.
    Brown MS; Goldstein JL
    Am J Clin Nutr; 1977 Jun; 30(6):975-8. PubMed ID: 194472
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterozygous familial hypercholesterolemia: failure of normal allele to compensate for mutant allele at a regulated genetic locus.
    Goldstein JL; Sobhani MK; Faust JR; Brown MS
    Cell; 1976 Oct; 9(2):195-203. PubMed ID: 184960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia.
    Bilheimer DW; Ho YK; Brown MS; Anderson RG; Goldstein JL
    J Clin Invest; 1978 Mar; 61(3):678-96. PubMed ID: 205553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.